Vaccination with Haemophilus influenzae type b conjugate vaccine reduces bacterial meningitis in Morocco

Vaccine

Volumn 30, Issue 15, 2012, Pages 2594-2599

  Braikat, Mohamed ^a   Barkia, Abdelaziz ^a   Mdaghri, Naima El ^b   Rainey, Jeanette J ^c   Cohen, Adam L ^c   Teleb, Nadia ^d  

^a Ministry of Health Morocco   (Morocco)

^b IBN ROCHD UNIVERSITY HOSPITAL   (Morocco)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^d WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

Bacterial meningitis surveillance; Eastern Mediterranean; Haemophilus influenzae type b vaccine; Morocco

Indexed keywords

HAEMOPHILUS INFLUENZAE TYPE B VACCINE;

ARTICLE; CHILD; DISEASE SURVEILLANCE; HAEMOPHILUS MENINGITIS; HUMAN; INCIDENCE; INFANT; INFECTION PREVENTION; MAJOR CLINICAL STUDY; MOROCCO; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; VACCINATION;

BACTERIAL CAPSULES; CHILD; CHILD, PRESCHOOL; HAEMOPHILUS VACCINES; HUMANS; INCIDENCE; INFANT; MENINGITIS, HAEMOPHILUS; MOROCCO;

EID: 84858289252     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2012.01.041     Document Type: Article

References (29)

1. World Health Organization The WHO position paper on Haemophilus influenzae type b conjugate vaccines. Wkly Epidemiol Rec 2006, 47:445-452.
2. Ojo L.R., O'Loughlin R.E., Cohen A.L., Loo J.D., Edmond K.M., Shetty S.S., et al. Global use of Haemophilus influenzae type b conjugate vaccine. Vaccine 2010, 28:7117-7122.
3. Shearer J.C., Stack M.L., Richmond M.R., Bear A.P., Hajjeh R.A., Bishai D.M. Accelerating policy decisions to adopt Haemophilus influenzae type b vaccine: a global, multivariable analysis. PLoS Med 2010, 7:e1000249.
4. Hajjeh R., Privor-Dumm L., Edmond K., O'Loughlin R., Shetty S., Griffiths U.K., et al. Supporting new vaccine introduction decisions: lessons learned from the Hib Initiative experience. Vaccine 2010, 28:7123-7129.
5. World Health Organization. Global framework for immunization monitoring and surveillance. WHO/IVB/07.06. Geneva: WHO. 2007 [accessed 14.09.10]. http://www.who.int/immunization/documents/WHO_IVB_07.06/en/index.html.
6. O'Loughlin R., Edmond K., Mangtani P., Cohen A.L., Shetty S., Hajjah R., et al. Methodology and measurement of the effectiveness of Haemophilus influenzae type b vaccine using observation study designs: systematic review. Vaccine 2010, 28:6128-6136.
7. Morris S.K., Moss W.J., Halsey N. Haemophilus influenzae type b conjugate vaccine use and effectiveness. Lancet Infect Dis 2008, 8:435-443.
8. Obonyo C.O., Lau J. Efficacy of Haemophilus influenzae type b vaccination of children: a meta-analysis. Eur J Clin Microbiol Infect Dis 2006, 25:90-97.
9. Lewis R.F., Kisakye A., Gessner B.D., Duku C., Odipio J.B., Iriso R., et al. Action for child survival: elimination of Haemophilus influenza type b meningitis in Uganda. Bull World Health Organ 2008, 86:292-301.
10. Baqui A.H., El Arifeen S., Saha S.K., Persson L., Zaman K., Gessner B.D., et al. Effectiveness of Haemophilus influenzae type B conjugate vaccine on prevention of pneumonia and meningitis in Bangladeshi children: a case-control study. Pediatr Infect Dis J 2007, 26:565-571.
11. Cowgill K.D., Ndiritu M., Nyiro J., Slack M.P., Chiphatsi S., Ismail A., et al. Effectiveness of Haemophilus influenzae type b conjugate vaccine introduction into routine childhood immunization in Kenya. JAMA 2006, 296:671-678.
12. Daza P., Banda R., Misoya K., Katsulukuta A., Gessner B.D., Katsande R., et al. The impact of routine infant immunization with Haemophilus influenzae type b conjugate vaccine in Malawi, a country with high human immunodeficiency virus prevalence. Vaccine 2006, 24:6232-6239.
13. Adegbola R.A., Secka O., Lahai G., Lloyd-Evans N., Njie A., Usen S., et al. Elimination of Haemophilus influenzae type b (Hib) disease from the Gambia after the introduction of routine immunisation with a Hib conjugate vaccine: a prospective study. Lancet 2005, 366:144-150.
14. Wenger J.D. Epidemiology of Haemophilus influenzae type b disease and impact of Haemophilus influenzae type b conjugate vaccines in the United States and Canada. Pediatr Infect Dis J 1998, 17:S132-S136.
15. U.S. Census Bureau, International Data Base, Morocco, Demographic Indicators: 1991 and 2009. [accessed 14.09.10]. http://www.census.gov/population/international/data/idb/informationGateway.php.
16. UN Data, Coutry Profiles, Morocco. 2007 [accessed 14.09.10]. http://data.un.org/CountryProfile.aspx.
17. World Health Organization. Eastern Mediterranean Regional Bacterial Meningitis Surveillance, Standard Operating Procedures. Unpublished report. Cairo, Egypt: Eastern Mediterranean Regional Office; 2004.
18. World Health Organization. Global literature review of Haemophilus influenzae type b and Streptococcus pneumoniae invasive disease among children less than five years of age 1980-2005. Geneva, Switzerland: World Health Organization. 2009 [accessed 14.09.10]. http://whqlibdoc.who.int/hq/2009/who_ivb_09.02_eng.pdf.
19. Liang K.Y., Zeger S.L. Longitudinal data analysis using generalized linear models. Biometrika 1996, 73:13-22.
20. Edmond K., Clack A., Korczak V.S., Sadnerson C., Griffiths U.K., Rudan I. Global and regional risk of disabling sequelae from bacterial meningitis: a systematic review and meta-analysis. Lancet Infect Dis 2010, 10:317-328.
21. Shetty S., Cohen A.L., Edmond K., Ojo L., Loo J., O'Loughlin R., et al. A systematic review and critical evaluation of invasive Haemophilus influenzae type b disease burden studies in Asia from the last decade: lessons learned for invasive bacterial disease surveillance. Pediatr Infect Dis J 2010, 29:653-661.
22. Amos B., Kisakye An Makewa D., Mudhune S., Mwamtemi H., Nansera D., Ngwiri T., et al. Behind the data: establishing the network for surveillance of pneumococcal disease in the East African region. Clin Infect Dis 2009, 48:S162-S171.
23. Levine O.S., Cherian T., Hajjeh R., Knoll M.D. Progress and future challenges in coordinated surveillance and detection of pneumonoccal and Hib disease in developing countries. Clin Infect Dis 2009, 48:S33-S36.
24. World Health Organization. Under five Hib and pneumococcal deaths and cases by country. Geneva, Switzerland: World Health Organization. 2009 [accessed 29.05.11]. http://www.who.int/immunization_monitoring/burden/Pneumo_hib_estimates/en/index1.html.
25. Gessner B.D., Sutanto A., Linehan M., Djelantik I.G., Fletcher T., Gerudug I.K., et al. Incidences of vaccine-preventable Haemophilus influenzae type b pneumonia and meningitis in Indonesian children: hamlet-randomised vaccine-probe trial. Lancet 2005, 365:43-52.
26. Mulholland K., Hilton S., Adegbola R., Usen S., Oparaugo A., Omosigho C., et al. Randomised trial of Haemophilus influenzae type-b tetanus protein conjugate vaccine [corrected] for prevention of pneumonia and meningitis in Gambian infants. Lancet 1997, 349:1191-1197.
27. Watt J.P., Wolfson L.J., O'Brien K.I., Henkle E., Deloria-Knoll M., McCall N., et al. Hib and pneumococcal global burden of disease study team. Burden of disease caused by Haemophilus influenzae type b in children younger than 5 years: global estimates. Lancet 2009, 374:903-911.
28. Adegbola R.A., Mulholland E.K., Secka O., Jaffar S., Greenwood B.M. Vaccination with a Haemophilus influenzae type b conjugate vaccine reduces oropharyngeal carriage of H. influenzae type b among Gambian children. J Infect Dis 1998, 177:1758-1761.
29. Murphy T.V., Pastor P., Medley F., Osterholm M.T., Granoff D.M. Decreased Haemophilus colonization in children vaccinated with Haemophilus influenzae type b conjugate vaccine. J Pediatr 1993, 122:517-523.